HC Wainwright reaffirmed their neutral rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report report published on Tuesday, Briefing.com Automated Import reports. HC Wainwright currently has a $57.00 price target on the medical instruments supplier’s stock, up from their previous price target of $55.00.
Other research analysts have also issued research reports about the stock. UBS Group lowered their price objective on shares of MEG Energy from C$8.70 to C$6.00 in a research note on Tuesday, March 12th. BidaskClub raised shares of Zebra Technologies from a hold rating to a buy rating in a research note on Saturday, July 6th. Zacks Investment Research raised shares of GALP ENERGIA SG/ADR from a sell rating to a hold rating in a research note on Monday, May 27th. William Blair reissued an outperform rating on shares of eXp World in a research note on Monday, March 18th. Finally, Wolfe Research assumed coverage on shares of Waters in a research note on Thursday, May 30th. They issued an underperform rating for the company. Eight investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $53.77.
Shares of XRAY stock opened at $56.77 on Tuesday. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $13.40 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.98. The stock’s 50-day moving average is $56.44. DENTSPLY SIRONA has a 1-year low of $33.93 and a 1-year high of $59.40.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.10. The company had revenue of $946.20 million during the quarter, compared to analyst estimates of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. DENTSPLY SIRONA’s revenue was down 1.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.45 earnings per share. As a group, sell-side analysts anticipate that DENTSPLY SIRONA will post 2.35 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be issued a $0.0875 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date is Thursday, June 27th. This represents a $0.35 annualized dividend and a yield of 0.62%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 17.41%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 9,160 shares of the firm’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $53.45, for a total transaction of $489,602.00. Following the sale, the director now owns 26,003 shares of the company’s stock, valued at $1,389,860.35. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Donald M. Jr. Casey acquired 10,000 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were bought at an average cost of $53.68 per share, for a total transaction of $536,800.00. Following the acquisition, the chief executive officer now owns 105,631 shares of the company’s stock, valued at approximately $5,670,272.08. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 26,417 shares of company stock worth $1,425,395 and sold 138,922 shares worth $7,631,805. 0.62% of the stock is owned by company insiders.
A number of hedge funds have recently added to or reduced their stakes in XRAY. Pinnacle Bank acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. Hanseatic Management Services Inc. acquired a new stake in DENTSPLY SIRONA during the first quarter worth approximately $30,000. Claybrook Capital LLC acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth approximately $38,000. Private Capital Group LLC raised its holdings in DENTSPLY SIRONA by 74.7% during the first quarter. Private Capital Group LLC now owns 1,223 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 523 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its holdings in DENTSPLY SIRONA by 1,047.2% during the first quarter. Quadrant Capital Group LLC now owns 1,411 shares of the medical instruments supplier’s stock worth $68,000 after purchasing an additional 1,288 shares in the last quarter. 91.66% of the stock is currently owned by institutional investors.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Why do companies engage in swaps?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.